Expert team
We connect experts
Together, we are creating an environment in which cutting-edge clinical trials can take place. See who is behind the development of clinical trials in the Czech Republic.
We are here to help you every step of the way, from design to implementation.
CZECRIN as a distributed network covering the whole Czech Republic and cooperating with most universities and university hospitals brings together a large expert capacity in all areas of expertise. The direct connection to the EU scientific area through the membership in ECRIN-ERIC enables the use of foreign expertise for the operation of CZECRIN.
CZECRIN experts
CZECRIN as a distributed network covering the whole Czech Republic and cooperating with most universities and university hospitals brings together a large expert capacity in all areas of expertise. The direct connection to the EU scientific area through the membership in ECRIN-ERIC enables the use of foreign expertise for the operation of CZECRIN.
prof. MUDr. Milan Brázdil, Ph.D., FRCP
Leading expert CZECRIN EPILEPSY
doc. MUDr. Vladimír Koblížek, Ph.D.
Leading expert CZECRIN PNEUMO
prof. MUDr. Dalibor Valík, Ph.D.
Head of ACIU
Advisory Board
CZECRIN International Advisory Committee
The CZECRIN Advisory Board (AB) was established in 2016 with the aim of linking CZECRIN’s scientific direction with global trends and to provide an independent, multinational perspective, advice and regular evaluation. The CZECRIN AB provides recommendations and suggestions as well as independent assessments in the areas of CZECRIN’s scientific activities, service portfolio, key areas of strategic development and international perspective and future direction. CZECRIN AB consists of highly qualified, nationally and internationally recognised experts, including also two members of the International Scientific Advisory Board (ISAB) of the partner institution FNUSA-ICRC. In 2020, the AB has nine members and the key areas represented are in line with CZECRIN’s core expertise – science, research and development in clinical medicine, regulatory affairs, clinical trials, ethical considerations and data management based on FAIR principles, scientific perspectives in biomedicine, social health, and education.
Kubiak Christine, PharmDr., Ph.D.
Mgr. Dvořáček Jakub, MHA, LL.M.
Deputy Minister of Health for the Czech Presidency
prof. Šabovič Mišo, MD
UMD Ljublana
Prof. Magnus Nilsson, MD, Ph.D.
Karolinska Institutet
Banzi Rita, MD, Ph.D.
Mario Negri Institute
Mgr. Koščík Michal, Ph.D.
MU Brno
Prof. Dr. med. Florian Lordick
University Cancer Center Leipzig